IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 3100 participants.
Also called NCT04221815
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 3,100 participants
- Registry
-
NCT04221815
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Cyprus, Germany, Greece, Israel, Italy, Sweden, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04221815. Randomized; single masking; primary purpose treatment. Start 2020-10-14 (actual); primary completion 2026-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact
- Acronym
- IMPROVE
- Condition
- Atherosclerosis
- Intervention (Device)
- Eagle Eye Platinum digital IVUS catheter with optional SyncVision
- Intervention (Device)
- Resolute Onyx Drug Eluting Stent
- Intervention (Device)
- Onyx Frontier Drug Eluting Stent
- Intervention (Device)
- Onyx TruStar Drug Eluting Stent
- Intervention (Device)
- Onyx TruCor Drug Eluting Stent
- Lead sponsor
- Medstar Health Research Institute
Record details
- Record id
cardio:ct-nct04221815- Content hash
8bf6593c6fdad0f3130a7b790bb15154865df9a6c9521e0325ddd95d207f3789